XRAY Ratios | P/E, ROE & Valuation

On the Key Ratios page for XRAY (XRAY), the latest P/E shown frames valuation, while ROE indicates profitability and capital efficiency. Together with the current ratio shown and debt-to-equity shown, these signals help you judge whether valuation is supported by fundamentals across the historical rows.

Financial Performance Ratios

XRAY Historical Per Share Metrics

···
Metric (FY)
Revenue per Share
Net Income per Share
Operating Cash Flow per Share
Free Cash Flow per Share
Cash per Share
Book Value per Share
Tangible Book Value per Share
Interest Debt per Share
CAPEX per Share

XRAY Historical Valuation Ratios

···
Metric (FY)
Price to Earnings (P/E)
Price to Book (P/B)
Price to Sales (P/S)
Enterprise Value to EBITDA
EV to Sales
EV to Operating Cash Flow
EV to Free Cash Flow
Enterprise Value

XRAY Historical Profitability Ratios

···
Metric (FY)
Return on Equity (ROE)
Return on Invested Capital (ROIC)
Return on Tangible Assets
Earnings Yield
Free Cash Flow Yield
Dividend Yield

XRAY Historical Liquidity & Financial Strength

···
Metric (FY)
Current Ratio
Interest Coverage
Income Quality
Debt to Equity
Debt to Assets
Net Debt to EBITDA

XRAY Historical Efficiency Ratios

···
Metric (FY)
Receivables Turnover
Payables Turnover
Inventory Turnover
Days Sales Outstanding
Days Payables Outstanding
Days of Inventory on Hand

XRAY Historical Market Metrics

···
Metric (FY)
Enterprise Value to EBITDA
Market Cap
Enterprise Value
Dividend Yield
Payout Ratio

Related peers

Compare More →
R
Ryder System, Inc.
$264.96
+1.76%
HAE
Haemonetics Corporation
$69.85
+6.03%
CON
Concentra Group Holdings Parent, Inc.
$24.92
+0.69%
A
Agilent Technologies, Inc.
$138.35
+0.70%
ICUI
ICU Medical, Inc.
$134.93
+3.38%
BEAM
Beam Therapeutics Inc.
$32.83
+11.10%

Frequently Asked Questions

Is XRAY stock overvalued based on its P/E ratio?

On this page, you can use the latest P/E (from the Key Ratios table) as your starting point and compare it to the company's multi-year P/E range in the historical rows. When the current P/E sits near its historical average, valuation may be broadly "in line." Investors typically then focus on trend direction (whether profitability and cash-flow metrics are improving) and balance-sheet risk (liquidity and leverage) rather than treating the P/E in isolation.

What is XRAY market cap?

Market cap is the market value of a company's equity and is commonly calculated as share price multiplied by shares outstanding. The Key Ratios table includes Market Cap so you can see the latest valuation size. Pair market cap with valuation multiples (P/E, P/B, P/S) so you can evaluate whether size also corresponds with "quality" and profitability. For a wider view across stocks, you can also use the stock screener.

What is a good P/E ratio for XRAY compared to its industry?

There isn't one universal "good" P/E - P/E should be judged against the business model and expected growth for its sector. A practical approach is: (1) compare the P/E on this page to XRAY's own historical range (shown across the table's rows), and (2) benchmark against peer companies using the Screener's P/E filters and the Peers Comparison/Compare tools. If profitability (ROE/ROIC) and cash-flow strength are improving, a higher P/E can be more defensible; if returns are slipping, even a lower P/E may be a value trap.

How does XRAY compare to its competitors in key financial ratios?

The fastest way to compare XRAY with competitors is to use the built-in "Peers Comparison" section on this page and the Compare tool. Focus on a small set of ratios that work together: P/E for valuation, ROE/ROIC for profitability and capital efficiency, current ratio and interest coverage for liquidity and solvency, and debt-to-equity for leverage risk. When you see XRAY outperform peers on profitability while keeping valuation and leverage reasonable, it often signals stronger fundamentals.

Is XRAY financially strong based on its ratios?

To assess whether XRAY is financially strong, review both profitability and balance-sheet risk together. Use the liquidity and leverage rows in the Key Ratios table (current ratio, interest coverage, and debt-to-equity) as your checklist for financial resilience. Then confirm the same story is supported by ROE/ROIC (quality of earnings) and by cash-flow backed metrics in the table.

What do XRAY's financial ratios say about its future growth?

Ratios are a way to see what the business is likely to sustain. Look for upward trends in profitability metrics (ROE and ROIC), improving earnings/cash-flow backed measures, and stable or strengthening liquidity. If XRAY is sustaining strong returns (for example ROE and ROIC) while debt levels and interest coverage remain manageable, growth expectations may be more credible. If valuation multiples expand while returns weaken, the market may be pricing optimistic growth ahead of results.